Wong Ivan, Worku Berhane, Weingarten Jeremy A, Ivanov Alexander, Khusid Felix, Afzal Ashwad, Tranbaugh Robert F, Gulkarov Iosif
Department of Medicine, NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY, USA.
Department of Cardiothoracic Surgery, NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY, USA.
Interact Cardiovasc Thorac Surg. 2017 Dec 1;25(6):937-941. doi: 10.1093/icvts/ivx237.
Failure of mechanical conventional ventilation (MCV) after cardiac surgery portends a dismal prognosis, with extracorporeal membrane oxygenation frequently utilized as a salvage therapy. We describe our experience with high-frequency percussive ventilation (HFPV) as a rescue therapy for hypoxaemia refractory to MCV after cardiac surgery.
In a 6-year retrospective analysis from 2009 to 2015, we identified 16 subjects who required HFPV after cardiac surgery. Data regarding demographics, intraoperative details, postoperative ventilatory settings including length of time on HFPV and postoperative outcomes were collected. The primary outcome was improvement in oxygenation as measured by pre- and post-HFPV partial pressures of oxygen (pO2) and ratio of pO2 to fraction of inspired oxygen (P/F ratio).
Sixteen patients required HFPV after cardiac surgery. Operative procedures included coronary artery bypass surgery (n = 6), aortic aneurysm or dissection repair (n = 5), valve with bypass surgery (n = 2), aortic valve replacement (n = 2) and extracorporeal membrane oxygenation (n = 1). Median pO2 increased from 61 to 149.5 mmHg (P < 0.001) and the median P/F ratio improved from 62 to 169 (P < 0.001). The improvement in pO2 and P/F ratio was durable at 24 h whether the patient was returned to MCV (n = 4) or remained on HFPV (n = 12) with pO2 and P/F ratio increasing from 61 to 104 mmHg (P < 0.001) and from 62 to 193.5 (P < 0.001), respectively. Survival to discharge was 81%.
In our cohort of cardiac surgical patients, HFPV was successfully utilized as a rescue therapy, obviating the need for extracorporeal membrane oxygenation. Although further studies are warranted, HFPV should be considered in cardiac surgical patients failing MCV.
心脏手术后机械常规通气(MCV)失败预示着预后不良,体外膜肺氧合常被用作挽救治疗。我们描述了我们将高频振荡通气(HFPV)作为心脏手术后对MCV难治性低氧血症的挽救治疗的经验。
在对2009年至2015年的6年回顾性分析中,我们确定了16例心脏手术后需要HFPV的患者。收集了有关人口统计学、术中细节、术后通气设置(包括HFPV使用时间)和术后结果的数据。主要结局是通过HFPV前后的氧分压(pO2)以及pO2与吸入氧分数之比(P/F比)来衡量的氧合改善情况。
16例患者心脏手术后需要HFPV。手术操作包括冠状动脉搭桥手术(n = 6)、主动脉瘤或夹层修复(n = 5)、瓣膜置换联合搭桥手术(n = 2)、主动脉瓣置换术(n = 2)和体外膜肺氧合(n = 1)。pO2中位数从61 mmHg升至149.5 mmHg(P < 0.001),P/F比中位数从62升至169(P < 0.001)。无论患者是恢复到MCV(n = 4)还是继续使用HFPV(n = 12),pO2和P/F比在24小时时的改善都是持久的,pO2分别从61 mmHg升至104 mmHg(P < 0.001),P/F比从62升至193.5(P < 0.001)。出院生存率为81%。
在我们的心脏手术患者队列中,HFPV成功用作挽救治疗,无需进行体外膜肺氧合。尽管需要进一步研究,但对于MCV失败的心脏手术患者应考虑使用HFPV。